A review of natural products and small‐molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challenges

Documenti analoghi

• Pathogen-specific drug metabolism in tuberculosis: Enzymes, metabolic pathways, and new horizons in therapeutic development.
  di: Vijayalakshmi, Periyasamy, et al.
  Pubblicazione: (2026)
• Application of artificial intelligence in clinical trials and drug development
  di: Addepalli Lakshmi Abhishek, Rachna Varma, Shweta Anand
  Pubblicazione: (2026)
• A review of nature's pharmacy: Unveiling the sources, classes and therapeutic potentials of natural products in drug discovery
  di: Muoegbunam, Juliet Chiamaka, et al.
  Pubblicazione: (2025)
• Development of phenyl‐urea‐based small molecules that target penicillin‐binding protein 4
  di: Vijay S. Gondil, et al.
  Pubblicazione: (2024)
• A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies
  di: Chen Zhao, et al.
  Pubblicazione: (2024)